23 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... SGLT2 inhibitors ... #table #comparison ... endocrinology #dm2
Therapy for AL Amyloidosis 2019 
 - Antibodies (Plasma cells) 
 - Proteasome Inhibitors 
 -
- Proteasome Inhibitors ... - Alkylating Agents ... ALAmyloidosis #Therapy #Medications ... #Therapies #Pharmacology ... #Management #Classes
Summary of Diuretic Agents 
Subclass, Drug, Mechanism of Action, Effects, Clinical Applications, Pharmacokinetics, Toxicities, Interaction
CARBONIC ANHYDRASE
Summary of Diuretic Agents ... others SGLT2 INHIBITORS ... #Diuretics #Medications ... #Pharmacology # ... summary #table #
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... - Pharmacology ... not definitively cause ... #Pharmacology # ... Summary #DM2 #diabetes
The 8 A’s — drugs that interact with warfarin
Antibiotics 
 - Most agents, but especially co-trimoxazole,
serotonin reuptake inhibitors ... cyclooxygenase-2 inhibitors ... #Interactions #Table ... Mnemonic #8As #Pharmacology ... #Medications
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... Diabetes #Mellitus #DM2 ... #pharmacology # ... comparison #table
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
SGLT2 Inhibitors ... anti-diabetic medications ... kidney), which causes ... #Pharmacology # ... Medications #DM2
This is an overview of the 3 main drug classes used to treat Hepatitis C

The new
Hepatitis C The new agents ... consist of Protease inhibitors ... NS5A, and NS5B inhibitors ... ambcarerx #HCV #Medications ... #DAAs #Pharmacology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
and Pharmacology ... Pharmacokinetics: • MOA: Inhibits ... activation to plasmin & inhibits ... arterial thrombotic events ... #Pharmacology #
Vasopressors and Inotropes - Pharmacology Summary
Vasopressors
Phenylephrine (alpha-1)
 • Increases BP, SVR
 • Risk of reflex bradycardia
and Inotropes - Pharmacology ... Preferred first agent ... • Higher doses cause ... Phosphodiesterase inhibitor ... Summary #management #medications